Track record · closed signal

Innoviva Inc (INVA) — closed signal from July 8, 2026

Partial Published before the outcome was known, scored automatically when the window closed on October 6, 2026 — -6.3% at the close.

Predicted vs. what happened

INVA price · publication thesis → realized outcomesplit-adjusted
$22.22 Published $26.22 Target $20.83 Window close $22.73 Peak
$21.40 – $22.40Entry zone — fair-value band
$22.22Published — price the day we called it
$26.22Target — the price the thesis aimed for
$22.73Peak — highest point inside the window, not a realized return
$20.83Window close — end-of-window price, context only

What happened

Partial

Reached 13% of the predicted growth at its peak, without hitting the target.

At window close
-6.3%
realized, from the publication price to the last close inside the window
Peak gain
+2.3%
peak, from the publication price — not a realized return
S&P 500, same window
+4.8%
SPY over the identical days, dividend-adjusted
Window close
$20.83
last close inside the window, ended October 6, 2026
Peak price
$22.73
peak on July 8, 2026 — not a realized return
Days to target
—

The thesis — published July 8, 2026

Predicted growth
+18%
over the measurement window
Target price
$26.22
the price the thesis aimed for
Entry zone
$21.40 – $22.40
the fair-value band we waited for
Price at publication
$22.22
published July 8, 2026
Confidence
72%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Innoviva looks like a cheap healthcare stock with clear product news from Nortiva Bio and a deal that could help sell XACDURO overseas. Trading is light and recent market momentum is weak, so the move is not yet confirmed. Strong cash flow and a solid balance sheet limit downside, creating an attractive but cautious near-term picture.

Primary drivers

  • Nortiva Bio provides a clear product development story
  • XACDURO deal could increase international sales
  • Low valuation gives a floor to downside risk
  • Light trading and weak momentum limit conviction

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All INVA signals